Yamamoto Y - Search Results

1

Nakamura M, Udagawa N, Yamamoto Y, Nakamura H. Nakamura M, et al. Among authors: yamamoto y. Clin Calcium. 2006 May;16(5):809-15. Clin Calcium. 2006. PMID: 16679623 Review. Japanese.

2

[The molecular mechanism of osteoclastic bone resorption and inhibitory drugs for bone resorption].

Yamamoto Y, Noguchi T, Udagawa N. Yamamoto Y, et al. Clin Calcium. 2005 Jul;15(7):11-6. Clin Calcium. 2005. PMID: 15995290 Review. Japanese.

3

Identification of cell cycle-arrested quiescent osteoclast precursors in vivo.

Mizoguchi T, Muto A, Udagawa N, Arai A, Yamashita T, Hosoya A, Ninomiya T, Nakamura H, Yamamoto Y, Kinugawa S, Nakamura M, Nakamichi Y, Kobayashi Y, Nagasawa S, Oda K, Tanaka H, Tagaya M, Penninger JM, Ito M, Takahashi N. Mizoguchi T, et al. Among authors: yamamoto y. J Cell Biol. 2009 Feb 23;184(4):541-54. doi: 10.1083/jcb.200806139. J Cell Biol. 2009. PMID: 19237598 Free PMC article.

4

Prostaglandin E2 strongly inhibits human osteoclast formation.

Take I, Kobayashi Y, Yamamoto Y, Tsuboi H, Ochi T, Uematsu S, Okafuji N, Kurihara S, Udagawa N, Takahashi N. Take I, et al. Among authors: yamamoto y. Endocrinology. 2005 Dec;146(12):5204-14. doi: 10.1210/en.2005-0451. Epub 2005 Sep 8. Endocrinology. 2005. PMID: 16150915

5

Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.

Yamamoto Y, Udagawa N, Matsuura S, Nakamichi Y, Horiuchi H, Hosoya A, Nakamura M, Ozawa H, Takaoka K, Penninger JM, Noguchi T, Takahashi N. Yamamoto Y, et al. Endocrinology. 2006 Jul;147(7):3366-74. doi: 10.1210/en.2006-0216. Epub 2006 Apr 20. Endocrinology. 2006. PMID: 16627581

6

Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand derived from osteoblasts.

Nakamichi Y, Udagawa N, Kobayashi Y, Nakamura M, Yamamoto Y, Yamashita T, Mizoguchi T, Sato M, Mogi M, Penninger JM, Takahashi N. Nakamichi Y, et al. Among authors: yamamoto y. J Immunol. 2007 Jan 1;178(1):192-200. doi: 10.4049/jimmunol.178.1.192. J Immunol. 2007. PMID: 17182555

7

Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes.

Yamamoto Y, Yamamoto Y, Udagawa N, Okumura S, Mizoguchi T, Take I, Yamauchi H, Yamauchi H, Noguchi T, Takahashi N. Yamamoto Y, et al. Cell Mol Biol (Noisy-le-grand). 2006 May 15;52(3):25-31. Cell Mol Biol (Noisy-le-grand). 2006. PMID: 17535751

8

[Effects of calcitonin on osteoclast].

Yamamoto Y, Noguchi T, Takahashi N. Yamamoto Y, et al. Clin Calcium. 2005 Mar;15(3):147-51. Clin Calcium. 2005. PMID: 15741694 Review. Japanese.

9

[Periodontal disease and systemic disease].

Yamamoto Y. Yamamoto Y. Clin Calcium. 2001 Mar;11(3):315-8. Clin Calcium. 2001. PMID: 15775524 Japanese.

10

Efficacy of Donepezil for Fatigue and Psychological Symptoms in Post-COVID-19 Condition: Study Protocol for a Multicenter Randomized, Placebo-controlled, Double-blind Trial.

Kawabata K, Nakamura K, Kondo K, Oka N, Ishii A, Idei M, Yamakawa K, Ie K, Yamamoto Y, Nishi K, Hirahata K, Kikuchi R, Yoshida H, Saito H, Goto T, Fujitani S. Kawabata K, et al. Among authors: yamamoto y. Ann Clin Epidemiol. 2024 Jul 18;6(4):87-96. doi: 10.37737/ace.24013. eCollection 2024 Oct 1. Ann Clin Epidemiol. 2024. PMID: 39726799 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,305 results

Search Page

Filters